Brian Albarran
Corporate Officer/Principal at KYMERA THERAPEUTICS, INC.
Network origin in Brian Albarran first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 38 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Brian Albarran via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Private Equity Investor Consultant / Advisor Private Equity Investor Consultant / Advisor Consultant / Advisor | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member Founder Chief Executive Officer Director/Board Member | |
Nimbus Apollo, Inc.
 Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Nimbus Apollo, Inc. provides drug discovery research services. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Chief Executive Officer | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member General Counsel Investor Relations Contact | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Atlas Venture Life Science Advisors LLC
 Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Impresa Management LLC
 Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Incendia Therapeutics, Inc.
 Incendia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Incendia Therapeutics, Inc. develops a novel class of anti-cancer therapies. The company is based in Boston, MA. The company was founded in 2003 by Laurent Audoly, Colin Glenn Begley, Olga Granaturova, Guy Travis Clifton. Laurent Audoly has been the CEO since 2003. | Pharmaceuticals: Major | Founder Director/Board Member | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BLUEBIRD BIO, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Corporate Officer/Principal | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree | |
Matchpoint Therapeutics, Inc.
 Matchpoint Therapeutics, Inc. BiotechnologyHealth Technology Matchpoint Therapeutics, Inc. is a biotechnology company based in Cambridge, MA. The company aims to discover and develop precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. Matchpoint's proprietary Advanced Covalent Exploration (ACE) platform integrates advanced chemoproteomics, machine learning, and covalent chemistry library evolution. The company was founded by Jianwei Che, Edward Chouchani, Tinghu Zhang, Nathanael S. Gray, and the CEO is G. Andre Turenne. | Biotechnology | Chairman Director/Board Member | |
| MERUS N.V. | Biotechnology | Director/Board Member Director/Board Member | |
Pfizer Venture Investments LLC
 Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments LLC (Pfizer Ventures Investments) is a venture capital subsidiary of Pfizer Inc. founded in 2001. The firm is headquartered in New York. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Imperial College London | College/University | Doctorate Degree Undergraduate Degree | |
Arkuda Therapeutics, Inc.
 Arkuda Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arkuda Therapeutics, Inc. engages in development of medicines to improve the lives of patients with neurological diseases. It leverages insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease. The company was founded by Gerhard Koenig and Duane Burnett in 2018 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
STORM Therapeutics Ltd.
 STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Jnana Therapeutics, Inc.
 Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | Biotechnology | Director/Board Member Chairman | |
Council on Foreign Relations, Inc.
 Council on Foreign Relations, Inc. Investment Trusts/Mutual FundsMiscellaneous Council on Foreign Relations, Inc. provides and disseminates ideas on foreign policies to individuals, corporate members, journalists and policy makers. It operates a forum for government officials, students and other interested parties to study and discuss world issues and impact on American foreign policies. The company publishes Foreign Affairs, a magazine that comes out six times a year, along with books and studies by its own scholars. Council on Foreign Relations was founded in 1921 and is headquartered in New York City, NY. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
Hydra Biosciences, Inc.
 Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA. | Pharmaceuticals: Major | Director/Board Member Human Resources Officer | |
Numerate, Inc.
 Numerate, Inc. Information Technology ServicesTechnology Services Numerate, Inc. operates as a technology platform company that leverages proprietary algorithms and cloud computing to transform the drug design process. The company was founded by Guido Lanza, Nigel P. Duffy, John Hampton Griffin and Brandon Allgood in 2007 and is headquartered in San Francisco, CA. | Information Technology Services | Director/Board Member Director/Board Member | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| BICYCLE THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Graduate Degree Undergraduate Degree | |
| THERAVANCE BIOPHARMA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
| University College London | College/University | Doctorate Degree | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder | |
| AVROBIO, INC. | Biotechnology | Chairman | |
| University of Cambridge | College/University | Undergraduate Degree | |
| MONTE ROSA THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| COGENT BIOSCIENCES, INC. | Biotechnology | Chairman | |
Warp Drive Bio, Inc.
 Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Padlock Therapeutics, Inc.
 Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member |
Statistics
International
| United States | 41 |
| United Kingdom | 7 |
| Netherlands | 2 |
| Mexico | 2 |
| Japan | 2 |
Sectoral
| Health Technology | 30 |
| Consumer Services | 11 |
| Finance | 6 |
| Commercial Services | 4 |
| Miscellaneous | 2 |
Operational
| Director/Board Member | 176 |
| Corporate Officer/Principal | 87 |
| Independent Dir/Board Member | 63 |
| Chairman | 39 |
| Undergraduate Degree | 34 |
Most connected contacts
| Insiders | |
|---|---|
| Bruce Booth | 40 |
| John Maraganore | 37 |
| Elaine Jones | 37 |
| Felix Baker | 28 |
| Wei Li | 24 |
| Steve Hall | 19 |
| Ellen Chiniara | 16 |
| Joanna Horobin | 15 |
| Donald Nicholson | 15 |
| Jeffrey Albers | 14 |
| Pamela Esposito | 13 |
| Michael J. Todisco | 12 |
| Leigh Morgan | 12 |
| Christopher O’Donnell | 11 |
| Laurent Audoly | 11 |
- Stock Market
- Insiders
- Brian Albarran
- Company connections
